Both in Pharmaceuticals
CDT Equity vs Matinas BioPharma Holdings
Over the past year CDT returned −100.0% and MTNB returned −93.2%; their daily moves had a correlation of -0.29.
CDT −100.0% MTNB −93.2%Growth of $1, one year, split-adjusted
| Metric | CDT | MTNB |
|---|---|---|
| Price | $1.31 | $1.19 |
| Market cap | $1.3M | $1.2M |
| Today | −92.26% | +2.59% |
| 1 month | −91.8% | −58.0% |
| 6 months | −100.0% | −87.6% |
| Year to date | −100.0% | −86.5% |
| 1 year | −100.0% | −93.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$390.0K | $755.0K |
| Dividend yield | — | — |
| Volatility (60d) | 1,261.4% | 775.6% |
| Short % of float | 18.8% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).